Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MGAT5 alters the severity of multiple sclerosis.
Brynedal B, Wojcik J, Esposito F, Debailleul V, Yaouanq J, Martinelli-Boneschi F, Edan G, Comi G, Hillert J, Abderrahim H. Brynedal B, et al. Among authors: edan g. J Neuroimmunol. 2010 Mar 30;220(1-2):120-4. doi: 10.1016/j.jneuroim.2010.01.003. Epub 2010 Feb 1. J Neuroimmunol. 2010. PMID: 20117844
Interleukin-1 receptor antagonist gene in multiple sclerosis.
Semana G, Yaouanq J, Alizadeh M, Clanet M, Edan G. Semana G, et al. Among authors: edan g. Lancet. 1997 Feb 15;349(9050):476. doi: 10.1016/S0140-6736(05)61188-9. Lancet. 1997. PMID: 9040586 No abstract available.
Survey of diagnostic and treatment practices for multiple sclerosis in Europe.
Fernández O, Delvecchio M, Edan G, Fredrikson S, Gionvannoni G, Hartung HP, Havrdova E, Kappos L, Pozzilli C, Soerensen PS, Tackenberg B, Vermersch P, Comi G. Fernández O, et al. Among authors: edan g. Eur J Neurol. 2017 Mar;24(3):516-522. doi: 10.1111/ene.13236. Epub 2017 Jan 31. Eur J Neurol. 2017. PMID: 28139062
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.
Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, Achiti I, Confavreux C, Coustans M, le Page E, Edan G, McDonnell GV, Hawkins S, Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, Zipp F, Miterski B, Epplen JT, Oturai A, Sørensen PS, Celius EG, Lara NT, Montalban X, Villoslada P, Silva AM, Marta M, Leite I, Dubois B, Rubio J, Butzkueven H, Kilpatrick T, Mycko MP, Selmaj KW, Rio ME, Sá M, Salemi G, Savettieri G, Hillert J, Compston DA. Roxburgh RH, et al. Among authors: edan g. Neurology. 2005 Apr 12;64(7):1144-51. doi: 10.1212/01.WNL.0000156155.19270.F8. Neurology. 2005. PMID: 15824338
HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis.
Cournu-Rebeix I, Génin E, Leray E, Babron MC, Cohen J, Gout C, Alizadeh M, Perdry H, Semana G, Brassat D, Clerget-Darpoux F, Yaouanq J, Edan G, Rosenheim M, Fontaine B. Cournu-Rebeix I, et al. Among authors: edan g. Genes Immun. 2008 Sep;9(6):570-4. doi: 10.1038/gene.2008.52. Epub 2008 Jul 10. Genes Immun. 2008. PMID: 18615093
A second-generation genomic screen for multiple sclerosis.
Kenealy SJ, Babron MC, Bradford Y, Schnetz-Boutaud N, Haines JL, Rimmler JB, Schmidt S, Pericak-Vance MA, Barcellos LF, Lincoln RR, Oksenberg JR, Hauser SL, Clanet M, Brassat D, Edan G, Yaouanq J, Semana G, Cournu-Rebeix I, Lyon-Caen O, Fontaine B; American-French Multiple Sclerosis Genetics Group. Kenealy SJ, et al. Among authors: edan g. Am J Hum Genet. 2004 Dec;75(6):1070-8. doi: 10.1086/426459. Epub 2004 Oct 19. Am J Hum Genet. 2004. PMID: 15494893 Free PMC article.
303 results